ATAI Life Sciences (ATAI) Twitter Mentions Statistics 2025

91 10.8%

1W 85.7% 1M 355%

Est. daily mentions on Twitter.

Similar companies

Company		Twitter Mentions
	Amgen AMGN	220 96.4%
	Gilead Sciences GILD	264 55.3%
	Catalyst Pharmaceuticals CPRX	82 27.4%
	Inovio Pharmaceuticals INO	747 73.3%
	Anavex Life Sciences AVXL	87 23%

Month over Month

Est. daily mentions on Twitter.

May 2025	52	55.2%
Apr 2025	33	15.9%
Mar 2025	40	55.4%
Feb 2025	89

How often is ATAI Life Sciences mentioned on Twitter?

ATAI Life Sciences was mentioned an estimated 91 times in various tweets yesterday. In the last 30 days, ATAI Life Sciences has been mentioned around 66 times per day.

Analyzing Twitter Mentions, how is ATAI Life Sciences performing compared to its industry peers?

ATAI Life Sciences underperforms its industry peers when it comes to Twitter Mentions, ranking in the 7th percentile.

Why is it important to track Twitter mentions for ATAI Life Sciences?

By monitoring Twitter mentions for ATAI Life Sciences, investors gain real-time insights into public sentiment towards the company, its products, and its industry. Positive mentions may indicate growing interest, customer satisfaction, or emerging trends, while negative mentions can alert investors to potential issues, controversies, or market challenges. By tracking these mentions over time, investors can identify patterns, spot emerging trends, and make informed decisions based on the evolving sentiment and public perception of ATAI Life Sciences, ultimately improving their investment strategies.

About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.